News
Company ImmuPharma PLC
TIDM IMM
Headline Appointment of Nomad
Released 12:27 16-Nov-07
Number 9018H
FOR IMMEDIATE RELEASE
London, 16 November 2007
Appointment of NOMAD and corporate broker
ImmuPharma plc (LSE:IMM), the specialist drug discovery and development company, is pleased to announce the appointment of Panmure Gordon & Co as its NOMAD and corporate broker with immediate effect.
For further information please contact:
ImmuPharma PLC
Richard Warr, Chairman
+44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Buchanan Communications + 44 20 7466 5000
Lisa Baderoon
Rebecca Skye-Dietrich
Panmure Gordon & Co +44 151 243 0963
Andrew Burnett
© London Stock Exchange plc. All rights reserved